Yahoo Finance

Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic

MARLBOROUGH, Mass. and WATERTOWN, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company ®, and Acrivon ...
WBJournal

Akoya Biosciences considering unsolicited buyout amidst merger proceedings

After biotech firm Akoya Biosciences previously announced it would be acquired by Billerica-based research corporation Quanterix, the Marlborough-based company is now considering an unsolicited, ...
Business Wire

Fiserv and Akoya Meet Consumer Demand for Anytime, Anywhere Financial Information with New Data Sharing Agreement

BROOKFIELD, Wis.--(BUSINESS WIRE)--Fiserv, Inc. (NYSE: FI), a leading global provider of payments and financial services technology, and Akoya, an API-only network for the consumer-permissioned ...
WBJournal

Anonymous party rescinds offer to buy Akoya Biosciences

Mere weeks after making an unsolicited bid to buy Marlborough-based biotech firm Akoya Biosciences, the anonymous party has withdrawn its offer. The unsolicited offer came May 21 after Akoya had ...
Yahoo Finance

Akoya Biosciences Sets a New Standard for Scaling Spatial Biology with the Launch of 2.0 Platforms

PhenoCycler-Fusion 2.0 enhancements enable the highest throughput workflow for spatial discovery studies. PhenoImager HT 2.0 delivers a 5x greater speed improvement for spatial studies in ...
Nasdaq

Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook

“The fourth quarter of 2023 is expected to be another record revenue quarter for Akoya, demonstrating our continued business momentum and commercial execution in the rapidly growing spatial biology ...
Nasdaq

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results

MARLBOROUGH, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the fourth quarter and ...
The Motley Fool

Why Shares of Akoya Biosciences Jumped on Tuesday

Akoya Biosciences makes single-cell imaging solutions to aid in phenotyping cells. The company is not profitable. Akoya's shares hit a 52-week low on June 8. Akoya executives purchased just more than ...
Digital Transactions

Fiserv’s Open Banking Move with Akoya Eases Secure Credential Sharing

Fiserv Inc. is working with data aggregator Akoya LLC to enable consumers to share their financial data with fintech and third-parties with which they do business in a way that doesn’t expose a ...
Business Wire

Akoya and Envestnet® | Yodlee® Take Milestone Step to Enhance API-Powered Consumer-Driven Sharing of Financial Data

BOSTON--(BUSINESS WIRE)--Akoya, a 100% API-connected data access network, announced today an agreement with leading data access platform Envestnet | Yodlee, to help consumers more efficiently manage ...
Seeking Alpha

Akoya Biosciences: 2024 Could Be The Year To Own Their Stock

Akoya Biosciences has seen a significant decline in its stock price but has recently bounced back by 55%. The company has shown consistent revenue growth over the past four years, with a projected ...